Some of the most seriously ill patients lack a natural antiviral. Franco-American researchers have just discovered the mechanisms involved.
Researchers are beginning to better understand the origin of severe forms of covid-19. In recent months, several teams had already shown that some of the patients requiring intensive care produced little or no type 1 interferon, a molecule that acts as an antiviral by blocking the replication of the virus in cells. At present, scientists from the “human genetics of infectious diseases” laboratory (Imagine Institute, Rockefeller center) are adding an additional stone to this edifice. Their work, published in the prestigious journal Science, has in fact made it possible to discover mechanisms that could explain the origin of this lack of interferon.
>> READ ALSO: Serious forms of Covid: a way to identify the people most at risk
Article reserved for subscribers
To continue reading, subscribe and take advantage of our BACK TO SCHOOL SPECIAL OFFER
1 € / month for 2 months
I subscribe now
Included in the Digital and Audio subscription
- Audio magazine and augmented digital magazine
- L’Express Masterclass
- Unlimited access to ad-free articles
- Access to all newsletters
Already a subscriber? To log in